About all

The gerson therapy success rate. Gerson Therapy Success Rate: 5-Year Survival Rates of Melanoma Patients

What are the 5-year survival rates for melanoma patients treated with Gerson diet therapy. How do these rates compare to conventional treatments. What does the retrospective review reveal about Gerson therapy effectiveness for different melanoma stages.

Содержание

Understanding Gerson Therapy for Melanoma Treatment

Gerson therapy is an alternative dietary approach used to treat various cancers, including melanoma. This retrospective review examines the 5-year survival rates of melanoma patients treated with Gerson’s diet therapy. The study aims to compare these rates with those reported in medical literature for conventional treatments.

What is Gerson Therapy?

Gerson therapy is a lactovegetarian diet characterized by:

  • Low sodium, fat, and (temporarily) protein content
  • High potassium and fluid intake
  • Hourly consumption of raw vegetable and fruit juices
  • Increased metabolism through thyroid supplementation
  • Limited calorie supply (2600-3200 calories per day)
  • Use of coffee enemas as needed for pain management and appetite stimulation

Study Design and Patient Demographics

The retrospective review was conducted at a hospital in Tijuana, Mexico. It included 153 white adult patients with superficial spreading and nodular melanoma, aged 25-72 years. The main outcome measure was the 5-year survival rate, categorized by the stage of melanoma at admission.

How was the study conducted?

The researchers analyzed patient records and compared the survival rates of those treated with Gerson therapy to published data on conventional treatments. They also proposed a new stage division for advanced melanoma:

  • Stage IVA: Distant lymph, skin, and subcutaneous tissue metastases
  • Stage IVB: Visceral metastases

Survival Rates for Early-Stage Melanoma

The study revealed impressive survival rates for patients with early-stage melanoma treated with Gerson therapy.

What were the survival rates for stages I and II melanoma?

For patients with stages I and II (localized) melanoma:

  • Gerson therapy: 100% 5-year survival rate (14 patients)
  • Conventional treatment (reported by Balch): 79% 5-year survival rate (15,798 patients)

This significant difference suggests that Gerson therapy may be particularly effective for early-stage melanoma patients.

Survival Rates for Regionally Metastasized Melanoma

The study also examined survival rates for patients with more advanced, regionally metastasized melanoma.

How did Gerson therapy perform for stage III melanoma?

For stage IIIA (regionally metastasized) melanoma:

  • Gerson therapy: 82% 5-year survival rate (17 patients)
  • Conventional treatment (Fachklinik Hornheide): 39% 5-year survival rate (103 patients)

For combined stages IIIA + IIIB (regionally metastasized) melanoma:

  • Gerson therapy: 70% 5-year survival rate (33 patients)
  • Conventional treatment (Fachklinik Hornheide): 41% 5-year survival rate (134 patients)

These results indicate that Gerson therapy may offer a significant survival advantage for patients with regionally metastasized melanoma.

Survival Rates for Advanced Melanoma

The study proposed a new stage division for advanced melanoma and examined survival rates for stage IVA patients.

Did Gerson therapy show promise for stage IV melanoma?

For stage IVA melanoma (distant lymph, skin, and subcutaneous tissue metastases):

  • Gerson therapy: 39% 5-year survival rate (18 patients)
  • Conventional treatment (Eastern Cooperative Oncology Group): 6% 5-year survival rate (194 patients)

While the survival rate for stage IVA melanoma treated with Gerson therapy was lower than for earlier stages, it was still significantly higher than the rate reported for conventional treatments.

The study did not assess the survival impact for stage IVB (visceral metastases) melanoma.

Gender Differences in Survival Rates

The study revealed interesting gender-based differences in survival rates for advanced melanoma.

Were there differences in survival rates between men and women?

For stages I-IIIB, male and female survival rates were identical. However, for stage IVA melanoma, women showed a strong survival advantage compared to men. This gender-based difference in survival rates for advanced melanoma warrants further investigation to understand the underlying factors.

Limitations and Considerations

While the results of this retrospective review are promising, it’s important to consider the limitations and potential biases of the study.

What factors should be considered when interpreting these results?

  • Sample size: The Gerson therapy group had relatively small sample sizes compared to the conventional treatment groups.
  • Selection bias: Patients who chose Gerson therapy might have had other factors influencing their survival rates.
  • Retrospective nature: The study design doesn’t allow for controlled comparisons or randomization.
  • Single-center study: Results may not be generalizable to all populations or treatment settings.
  • Lack of control group: The study compared results to published data rather than a direct control group.

These factors underscore the need for larger, prospective, controlled studies to further validate the effectiveness of Gerson therapy for melanoma treatment.

Implications for Melanoma Treatment

The results of this retrospective review suggest that Gerson therapy may offer significant survival benefits for melanoma patients across various stages of the disease.

How might these findings impact melanoma treatment approaches?

The considerably higher 5-year survival rates reported for Gerson therapy, particularly for stage IIIA/B males, could prompt further research into dietary interventions for melanoma treatment. These findings may encourage:

  • Integration of dietary approaches into conventional melanoma treatment protocols
  • Further investigation into the mechanisms by which Gerson therapy might impact melanoma progression
  • Exploration of gender-based differences in response to dietary interventions for advanced melanoma
  • Development of randomized controlled trials to more rigorously assess the efficacy of Gerson therapy
  • Consideration of Gerson therapy as a complementary approach alongside conventional treatments

While these results are promising, it’s crucial to note that Gerson therapy should not be considered a replacement for conventional melanoma treatments without further research and clinical validation.

Future Research Directions

The findings of this retrospective review open up several avenues for future research in the field of dietary interventions for melanoma treatment.

What areas of research should be prioritized based on these findings?

To build upon the results of this study, future research efforts could focus on:

  1. Conducting prospective, randomized controlled trials comparing Gerson therapy to conventional treatments
  2. Investigating the biological mechanisms by which Gerson therapy might influence melanoma progression
  3. Exploring the potential synergistic effects of combining Gerson therapy with conventional treatments
  4. Examining the impact of specific components of Gerson therapy (e.g., high potassium intake, coffee enemas) on melanoma outcomes
  5. Investigating the reasons behind the observed gender differences in survival rates for advanced melanoma
  6. Assessing the quality of life and side effect profiles of patients undergoing Gerson therapy compared to conventional treatments
  7. Evaluating the long-term effects of Gerson therapy on overall health and cancer recurrence rates

These research directions could help establish a more comprehensive understanding of the potential role of dietary interventions in melanoma treatment and potentially lead to improved outcomes for patients.

Nutritional Considerations in Cancer Treatment

The promising results of Gerson therapy in this study highlight the potential importance of nutrition in cancer treatment, particularly for melanoma.

How might nutrition impact cancer progression and treatment outcomes?

Nutrition can play a crucial role in cancer treatment through various mechanisms:

  • Modulation of inflammation: Certain dietary components can help reduce chronic inflammation, which is associated with cancer progression.
  • Immune system support: A balanced diet rich in fruits and vegetables can boost the immune system, potentially enhancing the body’s ability to fight cancer cells.
  • Antioxidant effects: Many plant-based foods contain antioxidants that may help protect cells from damage and slow cancer growth.
  • Hormonal regulation: Dietary factors can influence hormone levels, which may impact the growth of hormone-sensitive cancers.
  • Gut microbiome modulation: The diet can affect the composition of gut bacteria, which may influence cancer progression and treatment response.

While the specific mechanisms by which Gerson therapy might impact melanoma progression are not fully understood, these general principles of nutritional oncology provide a framework for further investigation.

What are the potential risks and benefits of dietary interventions in cancer treatment?

Potential benefits of dietary interventions like Gerson therapy include:

  • Improved overall health and well-being
  • Enhanced immune function
  • Reduced side effects from conventional treatments
  • Potential synergistic effects with conventional therapies
  • Increased sense of control and empowerment for patients

However, there are also potential risks to consider:

  • Nutritional deficiencies if the diet is too restrictive
  • Interference with conventional treatments if not properly managed
  • Financial burden due to the cost of specialized diets and supplements
  • Psychological stress from adhering to a strict dietary regimen
  • Delay in seeking conventional treatment if relied upon exclusively

It’s crucial for patients to discuss any dietary interventions with their healthcare team to ensure safe and effective integration with their overall treatment plan.

Patient-Centered Approach to Melanoma Treatment

The findings of this study underscore the importance of considering patient preferences and alternative approaches in melanoma treatment.

How can healthcare providers incorporate these findings into patient care?

To provide comprehensive, patient-centered care for melanoma patients, healthcare providers could:

  • Discuss the potential benefits and limitations of dietary interventions like Gerson therapy
  • Offer nutritional counseling as part of the overall treatment plan
  • Collaborate with integrative medicine specialists to develop comprehensive treatment strategies
  • Monitor patients closely if they choose to incorporate dietary interventions alongside conventional treatments
  • Encourage participation in clinical trials investigating dietary approaches to melanoma treatment
  • Provide support for patients in making informed decisions about their treatment options

By adopting a more holistic approach to melanoma treatment that considers both conventional and complementary therapies, healthcare providers may be able to improve patient outcomes and quality of life.

What role does patient empowerment play in cancer treatment?

Patient empowerment is increasingly recognized as a crucial factor in cancer treatment outcomes. By providing patients with information about various treatment options, including dietary interventions like Gerson therapy, healthcare providers can:

  • Enhance patient engagement in their treatment process
  • Improve treatment adherence and patient satisfaction
  • Reduce anxiety and improve psychological well-being
  • Promote a sense of control and self-efficacy in managing the disease
  • Facilitate shared decision-making between patients and healthcare providers

Empowered patients who feel informed and involved in their treatment decisions may be more likely to adhere to their treatment plans and experience better overall outcomes.

Challenges in Studying Alternative Cancer Therapies

While the results of this retrospective review are intriguing, they also highlight the challenges inherent in studying alternative cancer therapies like Gerson therapy.

What obstacles exist in researching alternative cancer treatments?

Several challenges complicate the study of alternative cancer therapies:

  • Funding limitations: Alternative therapies often lack the financial backing of pharmaceutical companies, making large-scale studies difficult to conduct.
  • Standardization issues: Alternative therapies like Gerson therapy can be complex and multifaceted, making it challenging to standardize treatments for research purposes.
  • Selection bias: Patients who choose alternative therapies may have different characteristics or motivations than those who opt for conventional treatments, potentially skewing results.
  • Ethical considerations: Randomized controlled trials may be challenging to conduct if patients have strong preferences for particular treatments.
  • Integration with conventional care: Studying alternative therapies in isolation may not reflect real-world scenarios where patients often combine multiple treatment approaches.
  • Long-term follow-up: Assessing the long-term effects of alternative therapies requires extended study periods, which can be costly and logistically challenging.

Overcoming these challenges will require innovative research designs, collaboration between conventional and alternative medicine practitioners, and sustained funding support for complementary and alternative medicine research.

How can the scientific community address these challenges?

To advance the study of alternative cancer therapies like Gerson therapy, the scientific community could:

  1. Develop standardized protocols for alternative therapies to ensure consistency in research studies
  2. Establish collaborations between conventional cancer centers and alternative medicine practitioners
  3. Utilize mixed-methods research designs that incorporate both quantitative and qualitative data
  4. Conduct pragmatic clinical trials that reflect real-world treatment scenarios
  5. Implement long-term patient registries to track outcomes of alternative therapy use over time
  6. Encourage funding bodies to support rigorous research into promising alternative therapies
  7. Promote open dialogue and knowledge sharing between conventional and alternative medicine communities

By addressing these challenges, the scientific community can work towards a more comprehensive understanding of the potential benefits and limitations of alternative cancer therapies, ultimately improving patient care and outcomes.

Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review

Comparative Study

. 1995 Sep;1(4):29-37.

G L Hildenbrand 
1
, L C Hildenbrand, K Bradford, S W Cavin

Affiliations

Affiliation

  • 1 Gerson Research Organization, San Diego, Calif., USA.
  • PMID:

    9359807

Comparative Study

G L Hildenbrand et al.

Altern Ther Health Med.

1995 Sep.

. 1995 Sep;1(4):29-37.

Authors

G L Hildenbrand 
1
, L C Hildenbrand, K Bradford, S W Cavin

Affiliation

  • 1 Gerson Research Organization, San Diego, Calif. , USA.
  • PMID:

    9359807

Abstract


Objective:

Compare 5-year melanoma survival rates to rates in medical literature.


Design:

Retrospective.


Setting:

Hospital in Tijuana, Mexico.


Patients:

White adult patients (N = 153) with superficial spreading and nodular melanoma, aged 25-72 years.


Intervention:

Gerson’s diet therapy: lactovegetarian; low sodium, fat and (temporarily) protein; high potassium, fluid, and nutrients (hourly raw vegetable/fruit juices). Metabolism increased by thyroid; calorie supply limited to 2600-3200 calories per day. Coffee enemas as needed for pain and appetite.


Main outcome measure:

5-year survival rates by stage at admission.


Results:

Of 14 patients with stages I and II (localized) melanoma, 100% survived for 5 years, compared with 79% of 15,798 reported by Balch. Of 17 with stage IIIA (regionally metastasized) melanoma, 82% were alive at 5 years, in contrast to 39% of 103 from Fachklinik Hornheide. Of 33 with combined stages IIIA + IIIB (regionally metastasized) melanoma, 70% lived 5 years, compared with 41% of 134 from Fachklinik Hornheide. We propose a new stage division: IVA (distant lymph, skin, and subcutaneous tissue metastases), and IVB (visceral metastases). Of 18 with stage IVA melanoma, 39% were alive at 5 years, compared with only 6% of 194 from the Eastern Cooperative Oncology Group. Survival impact was not assessed for stage IVB. Male and female survival rates were identical for stages I-IIIB, but stage IVA women had a strong survival advantage.


Conclusions:

The 5-year survival rates reported here are considerably higher than those reported elsewhere. Stage IIIA/B males had exceptionally high survival rates compared with those reported by other centers.

Similar articles

  • Pregnancy and early-stage melanoma.

    Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ.

    Daryanani D, et al.
    Cancer. 2003 May 1;97(9):2248-53. doi: 10.1002/cncr.11321.
    Cancer. 2003.

    PMID: 12712479

  • Malignant melanoma in Turkey: a single institution’s experience on 475 cases.

    Tas F, Kurul S, Camlica H, Topuz E.

    Tas F, et al.
    Jpn J Clin Oncol. 2006 Dec;36(12):794-9. doi: 10.1093/jjco/hyl114. Epub 2006 Oct 23.
    Jpn J Clin Oncol. 2006.

    PMID: 17060409

  • Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.

    Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.

    Poo-Hwu WJ, et al.
    Cancer. 1999 Dec 1;86(11):2252-8.
    Cancer. 1999.

    PMID: 10590365

  • Survival rates of sinonasal squamous cell carcinoma with the new AJCC staging system.

    Lee CH, Hur DG, Roh HJ, Rha KS, Jin HR, Rhee CS, Min YG.

    Lee CH, et al.
    Arch Otolaryngol Head Neck Surg. 2007 Feb;133(2):131-4. doi: 10.1001/archotol.133.2.131.
    Arch Otolaryngol Head Neck Surg. 2007.

    PMID: 17309980

  • Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.

    Lawenda BD, Arnold MG, Tokarz VA, Silverstein JR, Busse PM, McIntyre JF, Deschler DG, Baldini EH, Kachnic LA.

    Lawenda BD, et al.
    Ear Nose Throat J. 2008 Nov;87(11):634-43.
    Ear Nose Throat J. 2008.

    PMID: 19006065

    Review.

See all similar articles

Cited by

  • Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.

    Kim T, Yoon S, Shin DE, Lee SC, Oh J, Lee SY, Kim DK, Kim S, Jung B, Kim M, Lee S.

    Kim T, et al.
    Cancer Res Treat. 2022 Jul;54(3):937-949. doi: 10.4143/crt.2021. 871. Epub 2021 Sep 30.
    Cancer Res Treat. 2022.

    PMID: 34607396
    Free PMC article.

  • Melanoma and brown seaweed: an integrative hypothesis.

    Teas J, Irhimeh MR.

    Teas J, et al.
    J Appl Phycol. 2017;29(2):941-948. doi: 10.1007/s10811-016-0979-0. Epub 2016 Oct 11.
    J Appl Phycol. 2017.

    PMID: 28458463
    Free PMC article.

  • Living proof and the pseudoscience of alternative cancer treatments.

    Vickers AJ, Cassileth BR.

    Vickers AJ, et al.
    J Soc Integr Oncol. 2008 Winter;6(1):37-40.
    J Soc Integr Oncol. 2008.

    PMID: 18302909
    Free PMC article.

    Review.

  • Nutrition and cancer: a review of the evidence for an anti-cancer diet.

    Donaldson MS.

    Donaldson MS.
    Nutr J. 2004 Oct 20;3:19. doi: 10.1186/1475-2891-3-19.
    Nutr J. 2004.

    PMID: 15496224
    Free PMC article.

  • Complementary or alternative? Stronger vs weaker integration policies.

    Hess DJ.

    Hess DJ.
    Am J Public Health. 2002 Oct;92(10):1579-81. doi: 10.2105/ajph.92.10.1579.
    Am J Public Health. 2002.

    PMID: 12356596
    Free PMC article.

Publication types

MeSH terms

Gerson therapy | Complementary and alternative therapy

Gerson therapy involves a specific organic vegetarian diet with nutritional supplements and enemas. There is no scientific evidence to use it as a treatment for cancer.

Summary

  • Gerson therapy uses a specific organic vegetarian diet, nutritional supplements and enemas to treat cancer
  • There is no scientific evidence that it can treat cancer or its symptoms
  • Gerson therapy can have severe side effects

What is Gerson therapy?

A German doctor called Max Gerson developed Gerson therapy in the 1920s and 30s. He claimed that it helped cure his migraine headaches. So, he went on to use it to treat other diseases such as tuberculosis and cancer.

You might also hear Gerson therapy called the:

  • Gerson diet
  • Gerson regimen
  • Gerson method

Followers believe that changes to diet and nutrient intake can help to treat cancer. They also think that cancer is a symptom of disease of the whole body. 

It aims to rid the body of toxins and strengthen the body’s immune system. This way supporters say it can bring the body back to its normal metabolic state, and the body can heal itself.

The Gerson regime has 3 main parts:

  • a strict organic vegetarian diet made up of fruit and vegetables high in potassium and low in sodium
  • vitamin and mineral supplements, and specific enzymes
  • coffee or castor oil enemas

Gerson therapists believe that people with cancer have too much salt (sodium) in their bodies. This is compared to the amount of potassium.

People following the therapy only eat organic, vegetarian food. This includes up to 13 glasses of fresh juices a day. It is believed that by doing so, it will restore the right balance. And that it will cleanse the liver. 

Up to 5 coffee enemas a day are also given. It is believed that coffee enemas further help to excrete toxins from the liver and colon. And that taking certain supplements and enzymes help the body to get rid of cancer cells.

Scientific research does not support any of these claims.

Why people with cancer use it

They hope it will control or cure their cancer

Your doctor may have told you that conventional treatments cannot cure your cancer. This can be tough to accept.

In this situation, many people look for alternative therapies, including diets such as Gerson. But there is no scientific evidence that the Gerson diet works. It may cause serious health problems and make you feel worse.

The Gerson Research Organisation published a study in 1995. It looked at people with melanoma skin cancer who were doing the Gerson regime. It found that people on the diet had higher survival rates. This was when compared to rates that were published in other scientific studies.  

But a review study in 2014 found that the 1995 research was not accurate. It also did not use a single classification of tumour staging. Tumour staging means the size of a cancer and how far it has spread. The researchers said that they couldn’t say whether the Gerson regime worked.

Gerson therapy is popular with many people who have advanced cancer. But we need more scientific research before it can be used as a treatment for cancer.

Diet may play an essential role in helping to prevent cancer. But there is no current evidence to say that drastic diet changes will kill cancer cells.

Talk to your doctor before making any decisions about following an alternative diet.

To feel more in control

Some people use alternative or complementary therapy to feel more in control of their cancer and its treatment.

To boost the immune system

Some people believe that Gerson therapy boosts their immune system. By doing so, it helps to fight their cancer.

There is no scientific evidence to prove this, partly because of lack of research. We, need more research to have proof. Only then can we say with certainty that Gerson therapy affects the immune system.

How you have it

The Gerson diet is a strict low salt, organic fruit and vegetable diet.

Each day you will need to:

  • drink 20 pounds (about 9 kilos) of crushed fruit and vegetables (one glass of juice hourly, 13 times each day)
  • have up to 5 coffee enemas and perhaps also castor oil enemas
  • take potassium and other supplements, including vitamin B12, pancreatic enzymes and thyroid supplements

You can have Gerson therapy by staying in a clinic, or you can do it yourself at home.

The Gerson Institute refers people to clinics licensed by them. Their most popular one is in Mexico and there is also one in Hungary.

Gerson therapists advertise their clinics as very safe, relaxing and caring. But it is worth finding out if they have the medical facilities needed if any emergencies arise.

People who go to these clinics sometimes say that they feel better psychologically. These places might be very relaxing and caring places to be. But the possible side effects of Gerson therapy are a cause of concern.

You might stay at the clinic for a couple of weeks and then go home to continue the treatment. Or you can order a home therapy deal on the internet.

Treatment can continue for a few months to a few years. Having this therapy at home takes a great deal of time, energy and commitment. It can be almost a full-time job.

Side effects

In some situations, the Gerson diet can cause severe side effects. Some are potentially harmful. Speak to your doctor first if you are thinking of using the Gerson diet.

Coffee enemas remove a lot of potassium from your body and have been known to cause:

  • infections
  • dehydration
  • fits
  • salt and other mineral imbalances in the body
  • heart and lung problems, even death
  • constipation and inflammation of the bowel (colitis) from regular, long term use of enemas which can weaken the bowel muscle

Other reported side effects include:

  • loss of appetite
  • diarrhoea and sickness
  • abdominal cramps
  • aching, fever and sweating
  • cold sores
  • dizziness and weakness

Research into Gerson therapy for cancer

There is no evidence to prove that Gerson therapy works as a cure for cancer. We need more research to compare it with accepted and proven treatments within properly organised clinical trials.

The National Cancer Institute in the USA did a review in 2010. They found no evidence that it helped people with cancer.

Researchers in the UK did a study of 6 patients in 2007. They found that this type of therapy seemed to help people feel better emotionally. It also reduced their need for painkillers. But this number of patients is very small, so these findings are not reliable. The researchers suggested that a clinical trial is necessary. This way it will be possible to see if Gerson therapy works as a cancer treatment.

A review study in 2014 looked at 13 different cancer diets. The researchers looked at all the previous research on Gerson therapy. They found that none of the previous reports on Gerson therapy proved that it was effective.

A study looked at the 5-year survival rate of 153 cancer patients. They found that there were higher survival rates in patients with melanoma, ovarian and colorectal cancer, who were undergoing Gerson therapy. This was compared to patients having other therapies. However, this study was done by the Gerson Research Organisation. The method they used is not reliable and flawed. A further review found the evidence and study unreliable. 

It is difficult to be sure if there is any benefit in using Gerson therapy from the research so far.

This is because:

  • record keeping during studies has been quite poor
  • it is a complex therapy that can go on over months or years
  • we can’t know what other factors might or might not affect the outcome during this time, including the environment or other treatments and diets
  • some promoters give only anecdotal evidence, meaning that they use an example of an occasional person getting better as evidence

How much it costs

Gerson therapy can be costly. Do consider the ongoing cost of the treatment before you start.

You will need to buy special equipment if you are thinking of having Gerson therapy at home. Buying organic fruit, vegetables, coffee and supplements will also be an ongoing cost.

You will have to pay for flights and accommodation if you are going to a special clinic in another country. This will be on top of the treatment. Depending on the treatments involved, the cost can be thousands of pounds.

A word of caution

Some elements of the Gerson diet are healthy. For example, eating low fat food and lots of fresh fruit and vegetables.

But it is not healthy if you are eating vast quantities of one food group in a certain way (juicing) without balancing it with other food groups. It can be harmful to people who are already weak and ill. There are also many possible side effects some of which can be severe.

Most Gerson therapists encourage people not to have chemotherapy while having their therapy. This is because they believe that chemotherapy damages immunity. They say that radiotherapy is more compatible with Gerson treatment.

It is up to you to decide whether you want to use any alternative therapy. Stopping your conventional cancer treatments and methods of symptom control can be harmful.

Talk to your specialist about any alternative or complementary therapies that you want to try. Find out all you can about the therapy before deciding to use it.

Many websites are advertising or promoting Gerson therapy. But reputable scientific cancer organisations do not support them. Do not believe information or pay for alternative cancer therapy over the internet.

  • Gerson regimen

    B Cassileth

    Oncology (Williston Park). February, 2010. Vol 24, (2):201.

  • Surviving Against All Odds: Analysis of 6 Case Studies of Patients With Cancer Who Followed the Gerson Therapy

    A Molassiotis and others

    Integrative Cancer Therapies, March, 2007. Vol 6, (1), 80-88.  

  • Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice.

    J Huebner and others

    Anticancer Research. 2014 January; 34(1):39-48.

  • The information on this page is based on literature searches and specialist checking. We used many references and there are too many to list here. If you need additional references for this information please contact [email protected] with details of the particular issue you are interested in.

Last reviewed: 

11 Oct 2022

Next review due: 

11 Oct 2025